Literature DB >> 71758

Specific suppression of MLC and CML by anti-idiotypic antibodies in the mouse.

E Wight, H Binz.   

Abstract

Rabbit antisera directed against idiotypic determinants of alloreactive mouse CBA anti-C57BL/6 T blasts were raised in the following manner: first, a rabbit serum directed against nonspecific CBA blasts cells was prepared by injecting CBA concanavalin A blasts three times at monthly intervals into a rabbit. Second, specific CBA anti-C57BL/6 T lymphoblasts were induced in a mixed lymphocyte culture (MLC), were purified by gravity sedimentation through a fetal calf serum gradient, and, finally, were incubated with the anti-blast serum from the first step. During this incubation, presumably all epitopes of the blast cell population were blocked by anti-blast antibodies, except for the greatly amplified set of CBA anti-C57BL/6 alloreactive idiotypes. The mixture was then injected into fresh rabbits, which were boosted with similar mixtures after 3 and 6 weeks. Blood samples were removed 10 days after each injection. Such sera, when used together with complement, inhibited specifically the stimulation of CBA cells by C57BL/6 antigens in MLC and the CBA anti-C57BL/6 killer cells.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 71758     DOI: 10.1111/j.1365-3083.1977.tb00417.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  3 in total

Review 1.  Recognition of antigens by T lymphocytes.

Authors:  H Binz; H Wigzell
Journal:  Mol Cell Biochem       Date:  1978-12-22       Impact factor: 3.396

2.  Induction of specific transplantation immune reactions using anti-idiotypic antibodies.

Authors:  H Frischknecht; H Binz; H Wigzell
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

3.  Definition of T cell idiotypes using anti-idiotypic antisera produced by immunization with T cell clones.

Authors:  A J Infante; P D Infante; S Gillis; C G Fathman
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.